Jazz Pharmaceuticals stock forecast
Jazz Pharmaceuticals (J7Z) Stock Forecast & Price Target
J7Z Analyst Ratings
J7Z Stock 12 Month Forecast
Average Price Target
CHF253.86▲(0.00% Upside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Ami Fadia | Needham | CHF260.13→CHF258.45 | buy | ― | Reiterated | 11/16/26 | ||
| Sean Laaman | Morgan Stanley | CHF267.68→CHF271.88 | buy | ― | Reiterated | 11/13/26 | ||
| Ashwani Verma | UBS | CHF273.56 | buy | ― | Reiterated | 11/13/26 | ||
| David Amsellem | Piper Sandler | CHF260.13→CHF276.91 | buy | ― | Reiterated | 11/12/26 | ||
| Etzer Darout | Barclays | CHF227.41→CHF230.76 | buy | ― | Reiterated | 11/03/26 | ||
| Mohit Bansal | Wells Fargo | CHF251.74 | buy | ― | Assigned | 11/03/26 | ||
| Gary Nachman | Canaccord Genuity | CHF251.74 | buy | ― | Reiterated | 11/03/26 | ||
| Leonid Timashev | RBC Capital | CHF248.38→CHF255.94 | buy | ― | Reiterated | 11/03/26 | ||
| Jessica Fye | J.P. Morgan | CHF251.74→CHF260.13 | buy | ― | Assigned | 11/03/26 | ||
| Annabel Samimy | Stifel Nicolaus | CHF230.76 | buy | ― | Reiterated | 11/03/26 | ||
| Joseph Thome | TD Cowen | CHF251.74 | buy | ― | Reiterated | 11/03/26 | ||
| Geoff Meacham | Citi | CHF272.72 | buy | ― | Reiterated | 11/02/26 | ||
| Jason Gerberry | Bank of America Securities | CHF262.65 | buy | ― | Reiterated | 11/02/26 | ||
| Gregory Renza | Truist Financial | CHF235.80→CHF239.99 | buy | ― | Reiterated | 10/07/26 | ||
| Jeffrey Walch | Bernstein | CHF192.16 | hold | ― | Reiterated | 09/25/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Ami FadiaNeedham | BuyReiteratedCHF260.13→CHF258.45 | 11/16/26 | ― | ||
| Sean LaamanMorgan Stanley | BuyReiteratedCHF267.68→CHF271.88 | 11/13/26 | ― | ||
| Ashwani VermaUBS | BuyReiteratedCHF273.56 | 11/13/26 | ― | ||
| David AmsellemPiper Sandler | BuyReiteratedCHF260.13→CHF276.91 | 11/12/26 | ― | ||
| Etzer DaroutBarclays | BuyReiteratedCHF227.41→CHF230.76 | 11/03/26 | ― | ||
| Mohit BansalWells Fargo | BuyAssignedCHF251.74 | 11/03/26 | ― | ||
| Gary NachmanCanaccord Genuity | BuyReiteratedCHF251.74 | 11/03/26 | ― | ||
| Leonid TimashevRBC Capital | BuyReiteratedCHF248.38→CHF255.94 | 11/03/26 | ― | ||
| Jessica FyeJ.P. Morgan | BuyAssignedCHF251.74→CHF260.13 | 11/03/26 | ― | ||
| Annabel SamimyStifel Nicolaus | BuyReiteratedCHF230.76 | 11/03/26 | ― | ||
| Joseph ThomeTD Cowen | BuyReiteratedCHF251.74 | 11/03/26 | ― | ||
| Geoff MeachamCiti | BuyReiteratedCHF272.72 | 11/02/26 | ― | ||
| Jason GerberryBank of America Securities | BuyReiteratedCHF262.65 | 11/02/26 | ― | ||
| Gregory RenzaTruist Financial | BuyReiteratedCHF235.80→CHF239.99 | 10/07/26 | ― | ||
| Jeffrey WalchBernstein | HoldReiteratedCHF192.16 | 09/25/26 | ― |
Best Analysts Covering Jazz Pharmaceuticals
Copying Joseph Thome's trades and holding each position for 3 Months would result in 63.64% of your transactions generating a profit, with an average return of +6.64% per trade.
Copying Joseph Thome's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +37.70% per trade.
Copying Joseph Thome's trades and holding each position for 2 Years would result in 95.45% of your transactions generating a profit, with an average return of +65.85% per trade.
J7Z Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 3 | 4 |
| Buy | 35 | 54 | 50 | 48 | 28 |
| Hold | 4 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 39 | 56 | 51 | 52 | 33 |
In the current month, J7Z has received 32 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. J7Z average Analyst price target in the past 3 months is 253.86.
J7Z Financial Forecast
J7Z Earnings Forecast
Next quarter’s earnings estimate for J7Z is CHF 5.87 with a range of CHF 4.47 to CHF 10.71. The previous quarter’s EPS was -CHF 3.27. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
J7Z Sales Forecast
Next quarter’s sales forecast for J7Z is CHF 1.08B with a range of CHF 1.06B to CHF 1.12B. The previous quarter’s sales results were CHF 1.05B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

